Dave Powell on why LifeArc is evolving the way we do our science – and the difference we hope it will make to people’s lives.
We’ve seen some exciting scientific progress, forged new partnerships and launched some new landmark initiatives.
Three-year partnership to improve healthcare for thousands of people across Europe living with bronchiectasis.
We cautiously welcome the Government's announcement on how their £50m commitment into MND research will be spent.
Results of an international repurposing study show favipiravir could help with COVID-19.
Welcome to Anna Tomlinson, who joins LifeArc as our first Chief Communications Officer.
First major funding call announced as part of our £100m Chronic Respiratory Infection Translational Challenge
More than 300,000 people in the UK are living with bronchiectasis and more than 10,000 have been diagnosed with cystic fibrosis.
LifeArc CEO Dr Melanie Lee welcomes the Government’s restatement of its commitment to increase R&D funding in today’s Autumn statement: “Today the Chancellor made it clear that UK life science is a key driver of growth. “I am delighted that promises to raise the research and development (R&D) budget have been protected. It is the […]